External Research Partnerships
FDA is engaged with the following institutions to conduct research to help inform the public and the agency’s policies regarding compounded drugs:
National Academies of Science, Engineering, and Medicine (NASEM) Partnership
FDA has engaged NASEM to conduct two studies related to compounded drug products:
Centers of Excellence in Regulatory Science and Innovation (CERSI) Partnerships
FDA is collaborating with the University of Maryland (UMD) and Johns Hopkins University (JHU), two of the agency’s CERSI partners, to gather and analyze information that will inform FDA’s policies on bulk drug substances that may be used in compounding by outsourcing facilities and help promote public awareness and understanding.
Related Content
Related Publications and Articles